An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% Hyaluronic acid gel for the treatment of actinic keratoses

Archives of Dermatology

Volumn 133, Issue 10, 1997, Pages 1239-1242

  Rivers, Jason K ^a   McLean, David I ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CT 1101; DICLOFENAC; HYALURONIC ACID; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; ECZEMA; FEMALE; GEL; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030841385     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.10.1239     Document Type: Article

References (21)

1. Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol. 1994;131: 455-464.
2. Marks R, Foley P, Goodman G, et al. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol. 1986;115:649-655.
3. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329:1147-1151.
4. Olsen EA, Abernethy ML, Kulp-Shorten C. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol. 1991;24:738-743.
5. Epstein E. Warning: masoprocol is a potent sensitizer. J Am Acad Dermatol. 1994; 31:295-297.
6. Pearlman DL. Weekly pulse dosing: effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratoses. J Am Acad Dermatol. 1991;25:665-667.
7. Unis ME. Short-term intensive 5-fluorouracil treatment of actinic keratoses. Dermatol Surg. 1995;21:162-163.
8. Gebhardt M, Reuter A, Knopf B, et al. Allergic contact dermatitis from topical diclofenac. Contact Dermatitis. 1994;30:183-184.
9. Brown MB, Marriot C, Martin GP. A study of the transdermal drug delivery properties of hyaluronan. In: Willoughby DA, ed. Fourth International Workshop on Hyaluronan in Drug Delivery. London, England: Royal Society of Medicine Press Round Table Series 45; 1995;53-71.
10. Spencer JM, Kahn SM, Jiang W, et al. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol. 1995;131:796-800.
11. Yang B, Zhang L, Turley E. Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J Biol Chem. 1993;268:8617-8623.
12. Hall CL, Yang B, Yang X, et al. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell. 1995;82:19-26.
13. Alam CAS, Colville-Nash PR, Seed MP, Willoughby DA. The topical or local administration of diclofenac and hyaluronan in combination results in angiostatic activity in the murine chronic granulomatous air pouch. In: Willoughby DA, ed. First International Workshop on Hyaluronan in Drug Delivery. London, England: Royal Society of Medicine Press Round Table Series 33; 1994:21-28.
14. Paganini-Hill A. Aspirin and the prevention of colorectal cancer: a review of the evidence. Semin Surg Oncol. 1994;10:158-164.
15. Parker AL, Kadakia SC, Maccini DM, et al. Disappearance of duodenal polyps in Gardner's syndrome with sulindac therapy. Am J Gastroenterol. 1993;88:93-94.
16. Fontan PA, Amura CR, Sordelli DO. Treatment with a non-steroidal anti-inflammatory agent delays the growth of spontaneous pulmonary metastases of a mammary adenocarcinoma of non-detected immunogenicity. Br J Cancer. 1992;66:800-804.
17. Panje WR. Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. Arch Otolaryngol. 1981;107:658-663.
18. Chao TY, Ting CS, Yeh MY, et al. Effects of indomethacin on lymphokine-activated killer cell activities in cancer patients. Tumour Biol. 1995;16:230-242.
19. Cross DS, Platt JL, Juhn SK, et al. Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck. Arch Otolaryngol. 1992;118:526-528.
20. Naylor MF, Boyd A, Smith DW, et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995;131:170-175.
21. Black HS, Herd JA, Goldberg LH, et al. Effect of a low-fat diet on the incidence of actinic keratosis. N Engl J Med. 1994;330:1272-1275.